Robert F. Apple
Chief Financial Officer, ANTARES PHARMA, INC.
Companies
- KAZIA THERAPEUTICS LTDBoard member Mar 18, 2026 to now1
- ANTARES PHARMA, INC.Board member Mar 11, 2016 to May 26, 20222
- ANTARES PHARMA, INC.Chief executive officer Mar 11, 2016 to May 26, 20222
- ANTARES PHARMA, INC.President Mar 11, 2016 to May 26, 20222
- ANTARES PHARMA, INC.Chief operating officer Feb 12, 2015 to Jun 1, 20153
- ANTARES PHARMA, INC.Chief financial officer Feb 13, 2006 to Jun 2, 20144
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ANTARES PHARMA, INC.0 shares5May 24, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- May 24, 2022Returned to company 374,099 shares at $5.60 of ANTARES PHARMA, INC.5
- May 24, 2022Returned to company 611,667 shares at $5.60 of ANTARES PHARMA, INC.5
- May 24, 2022Returned to company 1,876,693 shares at $5.60 of ANTARES PHARMA, INC.5
- Mar 3, 2022Shares withheld for tax 37,695 shares at $3.80 of ANTARES PHARMA, INC.6
- Mar 3, 2022Granted 86,814 shares of ANTARES PHARMA, INC.6
- Feb 16, 2022Shares withheld for tax 34,282 shares at $3.66 of ANTARES PHARMA, INC.7
- Feb 16, 2022Granted 76,893 shares of ANTARES PHARMA, INC.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARKAZIA THERAPEUTICS LTD, Board member
- 2SEC EDGARANTARES PHARMA, INC., Board member
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Mar 4, 2022
- 7SEC EDGARForm 4 filed Feb 18, 2022